Comparing the Therapy of Otomycosis Using Clotrimazole with Iodine Tincture: A Clinical Trial

Document Type : Original

Authors

1 Department of Ears Nose and Throat, School of Medicine, Birjand University of Medical Sciences, Birjand, Iran.

2 Student Research Committee, Birjand University of Medical Sciences, Birjand, Iran.

3 Infectious Diseases Research Center, Birjand University of Medical Sciences, Birjand, Iran.

Abstract

Introduction:
Otomycosis, as a common superficial fungal infection, is the term to infection of external auditory canal. Despite numerous studies on diverse antifungal agents, there is no common consent on effective agent for treatment of otomycosis.  Therefore, the purpose of this study is compared therapy of otomycosis using two therapeutic agents; clotrimazole and iodine tincture.
 
Materials and Methods:
This research is a clinical trial study included 160 patients who were presented otomycosis. All patients were randomly assigned into two therapeutic groups of clotrimazole and Iodine Tincture (80 cases in each group). The results of response to thrapy were evaluated on 4, 10, and 20 days. Statistical analyses were performed using Independent-Samples t-test, Chi-Square, and Fishers҆ Exact tests in SPSS software v.18, in 0.05 significant level.
 
Results:
Fungal species were isolated including Aspergillus (72.5%) and Candida albicans (22.5%). After 4thday of treatment, 7.5% of the tincture group and 11.2% of the clotrimazole group revealed a good response to treatment (P=0.30). A good response to treatment was observed in35.0 and 41.2% of the patients on 10th day of treatment (P=0.44); and in 67.5 and 62.5% of the patients on 20th day of treatment (P= 0.20). There was no significant relationship between the two therapeutic arms.
 
Conclusion:
In this study, both clotrimazole and tincture showed the identical therapeutic efficacy on otomycosis. Our findings suggested that tincture can be used as a supplementary antifungal option for treatment of otomycosis.

Keywords

References

  1. Ong Y, Chee G. Infections of the external ear. Ann Acad Med Singapore. 2005; 34(4):330-4.
  2. Mahmoudabadi AZ. Mycological studies in 15 cases of otomycosis. Pakistan Journal of Medical Sciences. 2006; 22(4):486.
  3. Prasad SC, Kotigadde S, Shekhar M, Thada ND, Prabhu P, D’Souza T, et al. Primary otomycosis in the Indian subcontinent: predisposing factors, microbiology, and classification. International journal of microbiology. 2014; 2014.
  4. Pakshir K, Sabayan B, Javan H, Karamifar K. Mycoflora of human external auditory canal in Shiraz, southern Iran. 2008.
  5. Ho T, Vrabec JT, Yoo D, Coker NJ. Otomycosis: clinical features and treatment implications. Otolaryngology-Head and Neck Surgery. 2006; 135(5):787-91.
  6. Romsaithong S, Tomanakan K, Tangsawad W, Thanaviratananich S. Effectiveness of 3 per cent boric acid in 70 per cent alcohol versus 1 per cent clotrimazole solution in otomycosis patients: a randomised, controlled trial. The Journal of laryngology and otology. 2016; 130(9):811.
  7. Vlastarakos PV, Nikolopoulos TP, Manolopoulos L, Ferekidis E, Kreatsas G. Treating common ear problems in pregnancy: what is safe? European archives of oto-rhino-laryngology. 2008; 265(2):139-45.
  8. Jackman A, Ward R, April M, Bent J. Topical antibiotic induced otomycosis. International journal of pediatric otorhinolaryngology. 2005; 69(6):
    857-60.
  9. Navaneethan N, YaadhavaKrishnan RPD. Type of antifungals: does it matter in empirical treatment of otomycosis? Indian Journal of Otolaryngology and Head & Neck Surgery. 2015; 67(1):64-7.
  10. Kaya AD, Kiraz N. In vitro susceptibilities of Aspergillus spp. causing otomycosis to amphotericin B, voriconazole and itraconazole. Mycoses. 2007; 50(6):447-50.
  11. Del Palacio A, Cuetara M, López‐Suso M, Amor E, Garau M. Randomized prospective comparative study: short‐term treatment with ciclopiroxolamine (cream and solution) versus boric acid in the treatment of otomycosis. Mycoses. 2002; 45(7‐8):317-28.
  12. Vennewald I, Klemm E. Otomycosis: diagnosis and treatment. Clinics in dermatology. 2010; 28(2):202-11.
  13. Sharada M, Neelesh N, Swaroop J, Waseem S, Hiremath S, Nagaraj E. Effectiveness of chloroxylenol and chlorhexidine--cetrimide disinfectants on fungal isolates from clinically suspected cases of uncomplicated otomycosis. Journal of Evolution of Medical and Dental Sciences. 2013; 2(34):6411-5.
  14. Munguia R, Daniel SJ. Ototopical antifungals and otomycosis: a review. International journal of pediatric otorhinolaryngology. 2008; 72(4):453-9.
  15. Selvaggi G, Monstrey S, Landuyt KV, Hamdi M, Blondeel P. The role of iodine in antisepsis and wound management: a reappraisal. Acta chirurgica belgica. 2003; 103(3):241-7.
  16. Petersen EE, Weissenbacher ER, Hengst P, Spitzbart H, Wolfgang W, Wolff F, et al. Local treatment of vaginal infections of varying etiology with dequalinium chloride or povidone iodine. Arzneimittelforschung. 2002; 52(09):706-15.
  17. Philip A, Thomas R, Job A, Sundaresan VR, Anandan S, Albert RR. Effectiveness of 7.5 percent povidone iodine in comparison to 1 percent clotrimazole with lignocaine in the treatment of otomycosis. International Scholarly Research Notices. 2013; 2013.
  18. Mofatteh MR, Yazdi ZN, Yousefi M, Namaei MH. Comparison of the recovery rate of otomycosis using betadine and clotrimazole topical treatment. Brazilian journal of otorhinolaryngology. 2018; 84(4):404-9.
  19. Series MH. Poisindex Management. Iodine/ Iodides. 2010.
  20. Kanakiriya S, De Chazal I, Nath KA, Haugen EN, Albright RC, Juncos LA. Iodine toxicity treated with hemodialysis and continuous venovenous hemodiafiltration. American journal of kidney diseases. 2003;41(3):702-8.
  21. Mao Y-C, Tsai W-J, Wu M-L, Ger J, Deng J-F, Yang C-C. Acute hemolysis following iodine tincture ingestion. Human & experimental toxicology. 2011; 30(10):1716-9.
  22. Pardhan B, Tuladhar N. Prevalence of otomycosis in outpatientdepartment of otolaryngology in Tribhuvan University Teaching Hospital, Kathmandu, Nepal. 2003.
  23. Kaur R, Mittal N, Kakkar M, Aggarwal AK, Mathur MD. Otomycosis: a clinicomycologic study. Ear, nose & throat journal. 2000;79(8):606-9.
  24. Arndt K, Bowers K. Manual of dermatologic therapeutics. (2002). Lippincott Williams & Wilkins, Philadelphia.
  25. Kiakojuri K, Roushan MRH, Sepidgar SAA. Suction clearance and 2% topical miconazole versus the same combination with acidic drops in the treatment of otomycosis. Southeast Asian journal of tropical medicine and public health. 2007; 38(4):749.
  26. Yeganeh-Moghadam A, Asadi MA, Dehghani R, Mahmoudabadi AZ, Raygan F, Hooshyar H, et al. Evaluating the effect of a mixture of alcohol and acetic acid for otomycosis therapy. Jundishapur Journal of Microbiology. 2010;3(2):66-70.
  27. Malik AA, Malik SN, Aslam MA, Rasheed D. Comparative efficacy of topical clotrimazole and 3% salicylic acid in otomycosis. Rawal Med J. 2012;13(37):46-9.
  28. Berjis N, Okhovat SA, Koujani ZS, Baradaran S. Comparing the Therapeutic Effect of Clotrimazole and Tolnaftate in Treating Variety of Fungal Species Producing Otomycosis in Alzahra and Kashani Hospitals, Iran. Journal of Isfahan Medical School. 2012;29(164).
  29. ŞAHİNER A, Halat E, YAPAR EA. Comparison of bactericidal and fungicidal efficacy of antiseptic formulations according to EN 13727 and EN 13624 standards. Turkish journal of medical sciences. 2019;49(5):1564-7.
  30. Dopcea G, Matei F. Review on some current skin antiseptics. Scientific Bulletin 12th Vol Bucharest, Romania: CERES Publishing House. 2018:147-58.
  31. Goldman M, Roy G, Frechette N, Decary F, Massicotte L, Delage G. Evaluation of donor skin disinfection Transfusion. 1997;37(3): 309-12.
  32. Strand CL, Wajsbort RR, Sturmann K. Effect of lodophor vs iodine tincture skin preparation on blood culture contamination rate. Jama. 1993; 269(8): 1004-6.

 

 

Iranian Journal of Otorhinolaryngology
Volume 33, Issue 4
July and August 2021
Pages 229-235

Files

Share

How to cite

Statistics